A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer.

NCT01785992 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: Irosustat

Sponsor

Imperial College London

Collaborators

[object Object]